Successful treatment of psoriatic onycho-pachydermo periostitis (POPP) with adalimumab

Arthritis and Rheumatism

Volumn 52, Issue 1, 2005, Pages 280-282

  Bongartz, T ^a,b   Harle P ^b   Friedrich, S ^b   Karrer, S ^b   Vogt, T ^b   Seitz, A ^b   Muller Ladner U ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; HLA B27 ANTIGEN; METHOTREXATE; ROFECOXIB;

ADULT; ANAMNESIS; ARTICLE; BACKACHE; BONE RADIOGRAPHY; BONE SCINTISCANNING; CASE REPORT; CLINICAL FEATURE; DRUG TOLERABILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; KNEE PAIN; LABORATORY TEST; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONYCHOLYSIS; PARAKERATOSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; PSORIATIC ONYCHO PACHYDERMO PERIOSTITIS; SIDE EFFECT; SKIN BIOPSY; TREATMENT FAILURE;

ADULT; ANTIBODIES, MONOCLONAL; ARTHRITIS, PSORIATIC; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PERIOSTITIS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 12344259371     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20763     Document Type: Article

References (16)

1. Fournie B, Viraben R, Durroux R, Lassoued S, Gay R, Fournie A. Psoriatic onycho-pachydermo-periostitis of the big toe: anatomoclinical study and physiopathogenic approach apropos of 4 cases. Rev Rhum Mal Osteoartic 1989;56:579-82. In French.
2. De Pontville M, Dompmartin A, de Raucourt S, Macro M, Remond B, Leroy D. Psoriatic onycho-pachydermo-periostitis. Ann Dermatol Venereol 1993;120:229-32. In French.
3. Anders HJ, Sanden S, Kruger K. Psoriatic onycho-pachydermo-periostitis. Z Rheumatol 2002;61:601-4. In German.
4. Kroiss MM, Vogt T, Finkenzeller T, Landthaler M, Stolz W. Psoriatic onycho-pachydermo-periostitis. Z Rheumatol 2002;61:598-600. In German.
5. Boisseau-Garsaud AM, Beylot-Barry M, Doutre MS, Beylot C, Baran R. Psoriatic onycho-pachydermo-periostitis: a variant of psoriatic distal interphalangeal arthritis? [review]. Arch Dermatol 1996;132:176-80.
6. Schroder K, Goerdt S, Sieper J, Krasagakis K, Almond-Roesler B, Orfanos CE. Psoriatic onycho-pachydermo-periostitis (POPP) [review]. Hautarzt 1997;48:500-3. In German.
7. Marguery MC, Baran R, Pages M, Bazex J. Psoriatic acropachydermy [review]. Ann Dermatol Venereol 1991;118:373-6. In French.
8. Grosshans E, Bosser V. A case for diagnosis: ungueal psoriasis. Ann Dermatol Venereol 1993;120:319-20. In French.
9. Bauza A, Redondo P, Aquerreta D. Psoriatic onycho-pachydermo periostitis: treatment with methotrexate [letter]. Br J Dermatol 2000;143:901-2.
10. Dosik JS. Psoriatic onycho-pachydermo-periostitis. Dermatol Online J [serial online]. 2001;7(1). URL: http://dermatology.cdlib.org/.
11. Fietta P, Manganelli P. Pachydermoperiostosis and psoriatic onychopathy: an unusual association. J Eur Acad Dermatol Venereol 2003;17:73-6.
12. Ziemer A, Heider M, Goring HD. Psoriasiform onychopachydermoperiostitis of the large toes: the OP3GO syndrome. Hautarzt 1998;49:859-62. In German.
13. McGonagle D, Conaghan PG, Emery P. Psoriatic arthritis: a unified concept twenty years on [published erratum appears in Arthritis Rheum 1999;42:1997]. Arthritis Rheum 1999;42:1080-6.
14. De Keyser F, Baeten D, van den Bosch F, Kruithof E, Mielants H, Veys EM. Infliximab in patients who have spondyloarthropathy: clinical efficacy, safety, and biological immunomodulation [review]. Rheum Dis Clin North Am 2003;29:463-79.
15. Davis JC Jr, van der Heijde D, Braun J, Dougados M, Cush J, Clegg DO, et al. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum 2003;48:3230-6.
16. Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 2000;356:385-90.